Russell Monroe Glass - 05 Jun 2025 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Director
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
4
Filing time
09 Jun 2025, 07:11:53 UTC
Previous filing
10 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glass Russell Monroe Director C/O EVOLENT HEALTH, INC., 1812 N. MOORE ST., STE. 1705, ARLINGTON /s/ Jonathan Weinberg, Attorney-in-fact 09 Jun 2025 0002012340

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +21,979 +154% $0.000000 36,251 05 Jun 2025 Direct F1, F2
holding EVH Class A Common Stock 6,046 05 Jun 2025 By trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Glass pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date.
F3 These shares are held in a trust for the benefit of the reporting person and his spouse. The reporting person and his spouse are co-trustees of the trust and share voting and dispositive power over the shares.